asa guidelines on glp-1 Photo by ‎Dr Wiam Hussein الدكتور وئام‎ (@drwiam) · July 3, 2026 New therapeutic agents for type

GLP-1 receptor agonists: Do not bypass the intestine Do not remove absorptive surface area Do not directly inhibit nutrient transporters Proceed to intake-based assessment

FDA labeling advises renal-function monitoring when adverse reactions could lead to volume depletion, especially during treatment initiation or dose escalation

They also discuss what makes some science bad science, modern misconceptions about obesity and its causes, and the surprising impact WWII had on obesity research

There is no definitive evidence supporting probiotics, digestive enzymes, or most other supplements specifically for GLP-1 nausea, though individual patients may report subjective benefit

A strong intensity was considered positive, regardless of the distribution

GLP-1 "companion products" that fill nutritional gaps created when people start eating less are among the supplements gaining in popularity, Dicker said